Cargando…
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new co...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652308/ https://www.ncbi.nlm.nih.gov/pubmed/33166369 http://dx.doi.org/10.1371/journal.pone.0242124 |
_version_ | 1783607685180030976 |
---|---|
author | Halatoko, Wemboo Afiwa Konu, Yao Rodion Gbeasor-Komlanvi, Fifonsi Adjidossi Sadio, Arnold Junior Tchankoni, Martin Kouame Komlanvi, Koffi Segbeaya Salou, Mounerou Dorkenoo, Ameyo Monique Maman, Issaka Agbobli, Amétépé Wateba, Majesté Ihou Adjoh, Komi Séraphin Goeh-Akue, Edem Kao, Yem-bla Kpeto, Innocent Pana, Paul Kinde-Sossou, Rebecca Tamekloe, Agbeko Nayo-Apétsianyi, Josée Assane, Simon-Pierre Hamadi Prine-David, Mireille Awoussi, Sossinou Marcel Djibril, Mohaman Mijiyawa, Moustafa Dagnra, Anoumou Claver Ekouevi, Didier Koumavi |
author_facet | Halatoko, Wemboo Afiwa Konu, Yao Rodion Gbeasor-Komlanvi, Fifonsi Adjidossi Sadio, Arnold Junior Tchankoni, Martin Kouame Komlanvi, Koffi Segbeaya Salou, Mounerou Dorkenoo, Ameyo Monique Maman, Issaka Agbobli, Amétépé Wateba, Majesté Ihou Adjoh, Komi Séraphin Goeh-Akue, Edem Kao, Yem-bla Kpeto, Innocent Pana, Paul Kinde-Sossou, Rebecca Tamekloe, Agbeko Nayo-Apétsianyi, Josée Assane, Simon-Pierre Hamadi Prine-David, Mireille Awoussi, Sossinou Marcel Djibril, Mohaman Mijiyawa, Moustafa Dagnra, Anoumou Claver Ekouevi, Didier Koumavi |
author_sort | Halatoko, Wemboo Afiwa |
collection | PubMed |
description | BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country. OBJECTIVE: This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé. MATERIALS AND METHODS: From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. RESULTS: A total of 955 participants with a median age of 36 (IQR 32–43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3–1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4–1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9–2.6%. CONCLUSION: The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening. |
format | Online Article Text |
id | pubmed-7652308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-76523082020-11-18 Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 Halatoko, Wemboo Afiwa Konu, Yao Rodion Gbeasor-Komlanvi, Fifonsi Adjidossi Sadio, Arnold Junior Tchankoni, Martin Kouame Komlanvi, Koffi Segbeaya Salou, Mounerou Dorkenoo, Ameyo Monique Maman, Issaka Agbobli, Amétépé Wateba, Majesté Ihou Adjoh, Komi Séraphin Goeh-Akue, Edem Kao, Yem-bla Kpeto, Innocent Pana, Paul Kinde-Sossou, Rebecca Tamekloe, Agbeko Nayo-Apétsianyi, Josée Assane, Simon-Pierre Hamadi Prine-David, Mireille Awoussi, Sossinou Marcel Djibril, Mohaman Mijiyawa, Moustafa Dagnra, Anoumou Claver Ekouevi, Didier Koumavi PLoS One Research Article BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country. OBJECTIVE: This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé. MATERIALS AND METHODS: From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. RESULTS: A total of 955 participants with a median age of 36 (IQR 32–43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3–1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4–1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9–2.6%. CONCLUSION: The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening. Public Library of Science 2020-11-09 /pmc/articles/PMC7652308/ /pubmed/33166369 http://dx.doi.org/10.1371/journal.pone.0242124 Text en © 2020 Halatoko et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Halatoko, Wemboo Afiwa Konu, Yao Rodion Gbeasor-Komlanvi, Fifonsi Adjidossi Sadio, Arnold Junior Tchankoni, Martin Kouame Komlanvi, Koffi Segbeaya Salou, Mounerou Dorkenoo, Ameyo Monique Maman, Issaka Agbobli, Amétépé Wateba, Majesté Ihou Adjoh, Komi Séraphin Goeh-Akue, Edem Kao, Yem-bla Kpeto, Innocent Pana, Paul Kinde-Sossou, Rebecca Tamekloe, Agbeko Nayo-Apétsianyi, Josée Assane, Simon-Pierre Hamadi Prine-David, Mireille Awoussi, Sossinou Marcel Djibril, Mohaman Mijiyawa, Moustafa Dagnra, Anoumou Claver Ekouevi, Didier Koumavi Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title | Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title_full | Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title_fullStr | Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title_full_unstemmed | Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title_short | Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 |
title_sort | prevalence of sars-cov-2 among high-risk populations in lomé (togo) in 2020 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652308/ https://www.ncbi.nlm.nih.gov/pubmed/33166369 http://dx.doi.org/10.1371/journal.pone.0242124 |
work_keys_str_mv | AT halatokowembooafiwa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT konuyaorodion prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT gbeasorkomlanvififonsiadjidossi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT sadioarnoldjunior prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT tchankonimartinkouame prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT komlanvikoffisegbeaya prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT saloumounerou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT dorkenooameyomonique prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT mamanissaka prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT agbobliametepe prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT watebamajesteihou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT adjohkomiseraphin prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT goehakueedem prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT kaoyembla prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT kpetoinnocent prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT panapaul prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT kindesossourebecca prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT tamekloeagbeko prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT nayoapetsianyijosee prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT assanesimonpierrehamadi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT prinedavidmireille prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT awoussisossinoumarcel prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT djibrilmohaman prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT mijiyawamoustafa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT dagnraanoumouclaver prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 AT ekouevididierkoumavi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020 |